• Publications
  • Influence
Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis
Background— Treatment of in-stent restenosis with paclitaxel-coated balloon catheter as compared with plain balloon angioplasty has shown surprisingly low late lumen loss at 6 months and fewer majorExpand
  • 445
  • 23
  • PDF
Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.
BACKGROUND Drug-eluting stents reduce restenosis in coronary arteries, but clinical trials have failed to prove their efficacy in peripheral arteries. We investigated the use of paclitaxel-coatedExpand
  • 606
  • 16
SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study.
OBJECTIVES This study sought to assess the safety and efficacy of paclitaxel-coated balloon (PCB) angioplasty in an international, multicenter, prospective, large-scale registry study. BACKGROUNDExpand
  • 164
  • 15
Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of Restenosis
Background—Drug-eluting stents have shown promising antirestenotic effects in clinical trials. Non–stent-based local delivery of antiproliferative drugs may offer additional flexibility and alsoExpand
  • 383
  • 12
  • PDF
Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group
AbstractAims Drug-coated balloon catheters (DCB) are a new clinical treatment modality for coronary and peripheral artery disease. The goal of the consensus group is to develop recommendations forExpand
  • 109
  • 12
Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction.
OBJECTIVES The Southwest German Interventional Study in Acute Myocardial Infarction (SIAM III) investigated potentially beneficial effects of immediate stenting after thrombolysis as opposed to aExpand
  • 260
  • 11
The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
AIMS High serum phosphate is linked to cardiovascular morbidity and mortality in the general population. Fibroblast growth factor 23 (FGF-23) is a critical phosphate regulating hormone, potentiallyExpand
  • 120
  • 10
CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
OBJECTIVES The aim of this study was to analyze the yet ill-defined relationship of distinct human monocyte subsets with cardiovascular outcomes in a broad patient population at cardiovascular risk.Expand
  • 375
  • 9
Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.
OBJECTIVES This study presents long-term clinical follow-up, including binary restenosis rate and major adverse cardiovascular events, of the PACCOCATH-ISR (Treatment of In-Stent Restenosis byExpand
  • 184
  • 9
Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.
BACKGROUND We are presenting an extension of a previously published trial on the efficacy and safety of a paclitaxel-coated balloon in coronary ISR in a larger patient population and after a completeExpand
  • 77
  • 8
...
1
2
3
4
5
...